Biofrontera Inc. Files 8-K/A Amendment

TL;DR

Biofrontera filed an amendment to an 8-K. No new info yet, check the details.

AI Summary

Biofrontera Inc. filed an amendment (8-K/A) on April 3, 2024, to a previous report dated March 26, 2024. The amendment pertains to 'Other Events' and does not specify any new material information beyond the initial filing's scope. The company is incorporated in Delaware and its principal executive offices are located in Woburn, Massachusetts.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to information previously disclosed by Biofrontera Inc. Investors should review the amendment for any updated details.

Risk Assessment

Risk Level: low — This is a procedural amendment to a previous filing, not indicating new material events or financial changes.

Key Players & Entities

• Biofrontera Inc. (company) — Registrant
• March 26, 2024 (date) — Date of earliest event reported
• April 3, 2024 (date) — Filing Date
• Delaware (jurisdiction) — State of incorporation
• Woburn, Massachusetts (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ch registered Common stock, par value $0.001 per share BFRI The Nasdaq Stock Mar

Filing Documents

• form8-ka.htm (8-K/A) — 43KB
• 0001493152-24-013031.txt ( ) — 263KB
• bfri-20240326.xsd (EX-101.SCH) — 4KB
• bfri-20240326_def.xml (EX-101.DEF) — 26KB
• bfri-20240326_lab.xml (EX-101.LAB) — 36KB
• bfri-20240326_pre.xml (EX-101.PRE) — 25KB
• form8-ka_htm.xml (XML) — 7KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A ( Amendment No. 1 ) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 26, 2024 Biofrontera Inc. (Exact name of registrant as specified in its charter) Delaware 001-40943 47-3765675 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 120 Presidential Way , Suite 330 Woburn , Massachusetts 01801 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (781) 245-1325 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.001 per share BFRI The Nasdaq Stock Market LLC Preferred Stock Purchase Rights The Nasdaq Stock Market LLC Warrants to purchase common stock BFRIW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (the "Exchange Act") (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Explanatory Note This Amendment No. 1 on Form 8-K/A (this "Amendment") is being filed by Biofrontera Inc. (the "Company") to amend the Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on March 26, 2024 (the "Original Form 8-K"). The Original Form 8-K reported, among other things, that the Company had established April 22, 2024 as the record date for the determination of stockholders entitled to notice of and to vote at its 2024 Annual Meeting of Stockholders to be held on June 12, 2024 (the "2024 Annual Meeting") . This Amendment is being filed solely to report that the Company has changed the record date from April 22, 2024 to April 15, 2024. Item 8.01 Other Events. On April 3, 2024, the Company changed the record date for the determination of stockholders entitled to notice of and to vote at the 2024 Annual Meeting from April 22, 2024, as reported in the Original Form 8-K, to April 15, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. April 3, 2024 (Date) Biofrontera Inc. (Registrant) By: /s/ E. Fred Leffler III E. Fred Leffler III Chief Financial Officer

View Full Filing

View this 8-K/A filing on SEC EDGAR